title: The effect of intrathecal selective agonists of Y1 and Y2 neuropeptide Y receptors on the flexor reflex in normal and axotomized rats.
abstract: We have examined the effects of intrathecal (i.t.) administration of [Leu31,Pro34]-neuropeptide Y (NPY) or NPY-(13-36), selective agonists of NPY Y1 or Y2 receptors, respectively, on the excitability of the flexor reflex in normal rats and after unilateral transection of the sciatic nerve. In rats with intact and sectioned sciatic nerves, i.t. [Leu31,Pro34]-NPY induced a similar biphasic effect on the flexor reflex with facilitation at low doses and facilitation followed by depression at high doses. In contrast, i.t. NPY-(13-36) only facilitated the flexor reflex in normal rats, and at high dose it caused ongoing discharges in the electromyogram. NPY-(13-36) caused dose-dependent depression of the flexor reflex in rats after sciatic nerve transection, in addition to its facilitatory effect. Topical application of [Leu31,Pro34]-NPY or NPY-(13-36) caused a moderate and brief reduction in spinal cord blood flow. No difference was noted between the vasoconstrictive effect of [Leu31,Pro34]-NPY and NPY-(13-36). It is suggested that activation of Y1 receptors may be primarily responsible for the reflex depressive effect of i.t. neuropeptide Y in rats with intact sciatic nerves, whereas both Y1 and Y2 receptors may be involved in mediating the depressive effect of NPY after axotomy.
authors.affiliation: Department of Medical Laboratory Sciences and Technology, Division of Clinical Neurophysiology, Karolinska Institutet, Huddinge University Hospital, Huddinge, Sweden.
authors.forename: I S
authors.initials: IS
authors.lastname: Xu
authors.forename: J X
authors.initials: JX
authors.lastname: Hao
authors.forename: X J
authors.initials: XJ
authors.lastname: Xu
authors.forename: T
authors.initials: T
authors.lastname: Hökfelt
authors.forename: Z
authors.initials: Z
authors.lastname: Wiesenfeld-Hallin
mesh_terms: D000818:Animals; D019771:Axotomy; D004305:Dose-Response Relationship, Drug; D005260:Female; D007278:Injections, Spinal; D009478:Neuropeptide Y / Q000031:analogs & derivatives / Q000494:pharmacology*; D009619:Nociceptors / Q000502:physiology; D010146:Pain / Q000503:physiopathology; D010446:Peptide Fragments / Q000494:pharmacology*; D010543:Peroneal Nerve / Q000601:surgery; D051381:Rats; D017207:Rats, Sprague-Dawley; D017476:Receptors, Neuropeptide Y / Q000819:agonists* / Q000502:physiology; D012018:Reflex / Q000187:drug effects*; D013116:Spinal Cord / Q000098:blood supply / Q000737:chemistry / Q000502:physiology; D013979:Tibial Nerve / Q000601:surgery
chemical_list: D009478:Neuropeptide Y; D010446:Peptide Fragments; D017476:Receptors, Neuropeptide Y; C062924:neuropeptide Y (13-36); C097212:neuropeptide Y-Y1 receptor; C095889:neuropeptide Y2 receptor; C062259:neuropeptide Y, Leu(31)-Pro(34)-